Healthcare Equipment and Supplies
Company Overview of Tangent Medical Technologies, Inc.
Tangent Medical Technologies, Inc., a development stage medical device company, focuses on the development and commercialization of IV therapy products. It offers NovaCath, a peripheral intravenous catheter system that integrates catheter stabilization, tubing management, closed system blood control, and passive needle encapsulation on IV start. The company develops Integrated Safety IV Catheter System to improve clinical outcomes and minimize occupational exposure to blood and standardize clinical practice; Advanced Catheter Stabilization that allows preserving catheter integrity; Next Generation Tubing Management to improve patient comfort and reduce various IV complications, including dis...
8170 Jackson Road
Ann Arbor, MI 48103
Founded in 2009
Key Executives for Tangent Medical Technologies, Inc.
Chairman of The Board and Chief Executive Officer
Co-Founder and Director of Product Development
Co-Founder and Director of Marketing
Co-Founder and Director of Research & Development
Compensation as of Fiscal Year 2014.
Tangent Medical Technologies, Inc. Key Developments
GE Capital, Healthcare Financial Services Provides Credit Facility to Tangent Medical, Inc
Feb 5 14
GE Capital, Healthcare Financial Services announced that it has provided a $5 million senior secured term loan credit facility to Tangent Medical, Inc. GE Capital, Healthcare Financial Services is acting as agent and sole lender for the credit facility. The financing will be used to support the company's commercialization and development efforts.
Tangent Medical Announces U.S. Launch of the NovaCat Integrated Iv Catheter System
Jun 26 13
Tangent Medical announced its commercial product launch and start to clinical evaluations in several healthcare facilities across the U.S. The commercialization of this product is the first significant advancement in the IV catheter market in more than a decade. NovaCath is the first safety IV catheter offering advanced catheter stabilization technology designed to exceed the high CDC, OSHA and INS standards for IV catheter stabilization. Its passive needle shielding technology and closed system design minimizes occupational exposure to blood to the lowest feasible extent. Several patented design features uniquely position NovaCath to offer healthcare facilities uncompromising safety and satisfaction – both to the clinician and the patient. NovaCath's ergonomic design and soft materials will improve patient comfort and minimize the risk of pressure ulcers that can result from use of traditional catheters. In addition, its 180-degree fluid-path turn eliminates the J-Loop, which can cause IV tubing snags and catheter dislodgement. NovaCath's pre-assembled, all-in-one system minimizes IV catheter set-up time and risk of touch-point contamination.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries